SEOUL (Reuters) - South Korea may secure additional coronavirus vaccines for 20 million people from U.S. drugmaker Novavax Inc, President Moon Jae-in said, according to a statement from the presidential office on Wednesday.
Novavax entered into a development and supply agreement for its vaccine with South Korea's SK bioscience Co last year, according to a statement in August.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!